Point72 Asia »

Lineage Cell Therapeutics In shares owned by Point72 Asia

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Point72 Asia from 13F filings

Historical chart of Point72 Asia investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Point72 Asia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Point72 Asia

Quarter filed Position value Share count Share price at filing
2025-09-30 $79k 47k 1.69
2025-06-30 $101k 111k 0.91

More positions owned by Point72 Asia

Cyberark Software SHS (CYBR)
Kellogg Company (K)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Norfolk Southern (NSC)
Seagate Technology Hldngs Pl Ord Shs (STX)
Chart Industries (GTLS)
Ceridian Hcm Hldg (DAY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Frontier Communications Pare (FYBR)
Alphabet Cap Stk Cl A (GOOGL)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Applied Optoelectronics (AAOI)

View all positions for Point72 Asia

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Raffles Associates
Brian McDonald
Millennium Management
Geode Capital Management
BlackRock
Renaissance Technologies
Dauntless Investment Group
State Street Corporation
Morgan Stanley
GSA Capital Partners
Red Crane Wealth Management
Northern Trust
Eudaimonia Asset Management

View all funds holding Lineage Cell Therapeutics In